oral fulvestrant (VeraMorph)

口服氟维司群 (VeraMorph)

Report date: 2025/12/26 17:54:07

Base Information

Drug Nameoral fulvestrant (VeraMorph)
Drug Alias NameVER001 (VeraMorph)
ClassificationSmall molecules > Steroids
Mechanisms of ActionEstrogen receptors antagonistsEstrogen receptors degraders
TargetsEstrogen receptors
Therapy Area/IndicationsMetastatic breast cancer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVeraMorph Inc
China Registration ClassN/A

Develop Information

Active CompaniesVeraMorph Inc
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancer
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A